References
- World Health Organization. Expanded programme on immunization: measles and hepatitis B. http://www.wpro.who.int/rcm/en/archives/rc54/rc_resolutions/wpr_rc54_r03.htm.
- English AI. Progress towards the 2012 measles elimination goal in WHO’s Western Pacific Region, 1990–2008[J]. Wkly Epidemiol Rec. 2009;84:271.
- Song QW, Su QR, Ma C, Hao LX, Wang HQ. Spatial autocorrelation analysis of measles in China, 2005–2014[J]. Zhonghua Yu Fang Yi Xue Za Zhi. Chinese J Preventive Medicine. 2016;50(7):615–19. doi:10.3760/cma.j.issn.0253-9624.2016.07.010.
- World Health Organization. Regional office for the Western Pacific. Measles-Rubella Bull. Jan. 2018;12(1). http://iris.wpro.who.int/handle/10665.1/14006.
- Aspects G. Global measles and rubella strategic plan, 2012–2020 [J]. Genet Aspects. 2012:16.
- National Bureau of statistics. Main data bulletin of the sixth national census of Beijing in 2010. 2012 Feb 28. http://www.stats.gov.cn/tjsj/tjgb/rkpcgb/dfrkpcgb/201202/t20120228_30381.html.
- Li J, Lu L, Liu DL, Ma R, Wu J, Pang XH. Measles epidemiology and elimination measure evaluation in Beijing, 2005–2010[J]. Dis Surveillance. 2012;46(9):353–57.
- Gay NJ. The theory of measles elimination: implications for the design of elimination strategies[J]. J Infect Dis. 2004;189(1):27–35. doi:10.1086/381592.
- Fine P, Eames K, Heymann DL. “Herd immunity”: a rough guide. Clin Infect Dis. 2011;52(7):911–16. doi:10.1093/cid/cir007.
- Hethcote HW. Measles and rubella in the United States. Am J Epidemiol. 1983;117:2–13. doi:10.1093/oxfordjournals.aje.a113511.
- Gidding HF, Quinn HE, Hueston L, Dwyer DE, McIntyre PB. Declining measles antibodies in the era of elimination: Australia’s experience[J]. Vaccine. 2018;36(4):507. doi:10.1016/j.vaccine.2017.12.002.
- Mcquillan GM, Kruszonmoran D, Hyde TB, Forghani B, Bellini W, Dayan GH. Seroprevalence of measles antibody in the US population, 1999–2004[J]. J Infect Dis. 2007;196(10):1459–64. doi:10.1086/522866.
- Tang J. Current status of serological research on measles antibody [J]. J Public Health Prev Med. 2010;21:48–49.
- Tang L, Zhou Y, Pan Y, Zhu H. Measles epidemics and seroepidemiology of population in Wujin, Changzhou city, Jiangsu province, China 2015[J]. Vaccine. 2017;35(22):2925–29. doi:10.1016/j.vaccine.2017.04.018.
- Orenstein WA, Gay NJ. The Theory of Measles Elimination: implications for the Design of Elimination Strategies [J]. J Infect Dis. 2004;189(1):27–35. doi:10.1086/381592.
- Zhang ZJZ, Suo LD, Ma R, Li J, Pan JB, Lu L. Epidemiological characteristics of measles in Beijing, 2011–2016[J]. International Journal of Virology. 2018;25(2):32–36. doi: 10.3760/cma.j.issn.1673-4092.2018.02.008
- Leuridan E, Sabbe M, Van DP. Measles outbreak in Europe: susceptibility of infants too young to be immunized.[J]. Vaccine. 2012;30(41):5905–13. doi:10.1016/j.vaccine.2012.07.035.
- Li J, Lu L, Chen M, Huang F, Zeng Y, Li X-M, Ma R, Pan J-B, Sun M, Sun H, et al. [Analysis of measles immunity level in persistent populations in Beijing, 2012][J]. Chinese J Preventive Medicine. 2013;47(10):916–919.
- Su QR, Xu AQ, Strebel P. National and international experts’ consensus on key technical issues of measles elimination in China[J]. Chinese Journal of Vaccines & Immunization. 2014(3):264–270.
- Lu L, Gu Y, Sun M. Epidemic characteristics of measles outbreak in floating population in Beijing and its control strategy[J]. Chin J Vaccines Immunization. 1999(2):69–71.
- Liu DL, Sun MP, Yang J. Analysis of epidemiology for measles in Beijing in 2003[J]. Chin J Vaccines Immunization. 2005, 11(1):30–32. doi: 10.3969/j.issn.1006-916X.2005.01.010.
- Ma C. Epidemiology of measles in China and immunization strategies for measles elimination[D]. Beijing, China: China Center for Disease Control and Prevention; 2014.
- Gao J. Investigation of measles antibody level of healthy people in Jing’an district of Shanghai City [J]. Chin J Dis Control Prev. 2010, 14(7):641–643.
- Beijing Statistics Bureau. Beijing statistical yearbook 2017[M], Beijing, China. 2018.